Mural Oncology Price Target Announced at $18.00/Share by HC Wainwright & Co.
Raymond James Initiates Mural Oncology(MURA.US) With Buy Rating, Announces Target Price $18
Mural Oncology Analyst Ratings
Raymond James Initiates Mural Oncology at Strong Buy With $18 Price Target
Morgan Stanley Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $13
Morgan Stanley Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $13
Buy Rating Affirmed for Mural Oncology Plc on Promising Clinical Trials and Innovative Cancer Therapies
Mural Oncology Analyst Ratings
Rodman & Renshaw Initiates Coverage On Mural Oncology With Buy Rating, Announces Price Target of $15
Mural Oncology Analyst Ratings
Morgan Stanley Initiates Coverage On Mural Oncology With Overweight Rating, Announces Price Target of $13